{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T02:10:41Z","timestamp":1740622241018,"version":"3.38.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,26]]},"DOI":"10.7759\/cureus.79718","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:36:56Z","timestamp":1740620216000},"source":"Crossref","is-referenced-by-count":0,"title":["Highly Aggressive Multiple Sclerosis Relapse During Pregnancy Following SARS-CoV-2 Infection: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Roman","family":"Meyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Sutak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian P","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Diem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000360528","article-title":"Multiple sclerosis: current knowledge and future outlook","volume":"72","author":"Kamm CP","year":"2014","unstructured":"Kamm CP, Uitdehaag BM, Polman CH. Multiple sclerosis: current knowledge and future outlook. Eur Neurol. 2014, 72:132-41. 10.1159\/000360528","journal-title":"Eur Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56020049","article-title":"Pregnancy and multiple sclerosis: an update on the disease modifying treatment strategy and a review of pregnancy's impact on disease activity","volume":"56","author":"Varyt\u0117 G","year":"2020","unstructured":"Varyt\u0117 G, Zakarevi\u010dien\u0117 J, Rama\u0161auskait\u0117 D, Lau\u017eikien\u0117 D, Arlauskien\u0117 A. Pregnancy and multiple sclerosis: an update on the disease modifying treatment strategy and a review of pregnancy's impact on disease activity. Medicina (Kaunas). 2020, 56:49. 10.3390\/medicina56020049","journal-title":"Medicina (Kaunas)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-022-05875-6","article-title":"Neurological toll of COVID-19","volume":"43","author":"Bhola S","year":"2022","unstructured":"Bhola S, Trisal J, Thakur V, Kaur P, Kulshrestha S, Bhatia SK, Kumar P. Neurological toll of COVID-19. Neurol Sci. 2022, 43:2171-86. 10.1007\/s10072-022-05875-6","journal-title":"Neurol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2358-c1","article-title":"Novel therapeutic strategies for multiple sclerosis: potential of intravenous immunoglobulin","volume":"8","author":"Bayry J","year":"2009","unstructured":"Bayry J, Lacroix-Desmazes S, Kaveri SV. Novel therapeutic strategies for multiple sclerosis: potential of intravenous immunoglobulin. Nat Rev Drug Discov. 2009, 8:594. 10.1038\/nrd2358-c1","journal-title":"Nat Rev Drug Discov"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2022.0489","article-title":"Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"79","author":"Chen J","year":"2022","unstructured":"Chen J, Huda S, Hacohen Y, et al.. Association of maintenance intravenous immunoglobulin with prevention of relapse in adult myelin oligodendrocyte glycoprotein antibody-associated disease. JAMA Neurol. 2022, 79:518-25.","journal-title":"JAMA Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.09.002","article-title":"Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey","volume":"26","author":"Nazareth TA","year":"2018","unstructured":"Nazareth TA, Rava AR, Polyakov JL, Banfe EN, Waltrip RW, Zerkowski KB, Herbert LB. Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey. Mult Scler Relat Disord. 2018, 26:219-34. 10.1016\/j.msard.2018.09.002","journal-title":"Mult Scler Relat Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102590","article-title":"Magnetic resonance imaging at baseline and follow-up to differentiate between pediatric monophasic acquired CNS demyelination and MS","volume":"46","author":"Boesen MS","year":"2020","unstructured":"Boesen MS, Blinkenberg M, Born AP, et al.. Magnetic resonance imaging at baseline and follow-up to differentiate between pediatric monophasic acquired CNS demyelination and MS. Mult Scler Relat Disord. 2020, 46:102590. 10.1016\/j.msard.2020.102590","journal-title":"Mult Scler Relat Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.10.1426","article-title":"Acute fulminant demyelinating disease: a descriptive study of 60 patients","volume":"64","author":"de Seze J","year":"2007","unstructured":"de Seze J, Debouverie M, Zephir H, et al.. Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol. 2007, 64:1426-32. 10.1001\/archneur.64.10.1426","journal-title":"Arch Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2023.06.009","article-title":"Updates in NMOSD and MOGAD diagnosis and treatment: a tale of two central nervous system autoimmune inflammatory disorders","volume":"42","author":"Cacciaguerra L","year":"2024","unstructured":"Cacciaguerra L, Flanagan EP. Updates in NMOSD and MOGAD diagnosis and treatment: a tale of two central nervous system autoimmune inflammatory disorders. Neurol Clin. 2024, 42:77-114. 10.1016\/j.ncl.2023.06.009","journal-title":"Neurol Clin"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD)\u00a0- revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis","volume":"270","author":"Jarius S","year":"2023","unstructured":"Jarius S, Aktas O, Ayzenberg I, et al.. Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD)\u00a0- revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis. J Neurol. 2023, 270:3341-68. 10.1007\/s00415-023-11634-0","journal-title":"J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.885218","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management","volume":"13","author":"Sechi E","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, et al.. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol. 2022, 13:885218. 10.3389\/fneur.2022.885218","journal-title":"Front Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/bs.irn.2022.06.011","article-title":"Sex and gender differences in autoimmune demyelinating CNS disorders: multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD)","volume":"164","author":"Diem L","year":"2022","unstructured":"Diem L, Hammer H, Hoepner R, Pistor M, Remlinger J, Salmen A. Sex and gender differences in autoimmune demyelinating CNS disorders: multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD). Int Rev Neurobiol. 2022, 164:129-78. 10.1016\/bs.irn.2022.06.011","journal-title":"Int Rev Neurobiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511435931","article-title":"Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort","volume":"18","author":"Lebrun C","year":"2012","unstructured":"Lebrun C, Le Page E, Kantarci O, Siva A, Pelletier D, Okuda DT. Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort. Mult Scler. 2012, 18:1297-302. 10.1177\/1352458511435931","journal-title":"Mult Scler"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1933","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses","volume":"73","author":"Pilotto A","year":"2021","unstructured":"Pilotto A, Masciocchi S, Volonghi I, et al.. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses. Clin Infect Dis. 2021, 73:e3019-26. 10.1093\/cid\/ciaa1933","journal-title":"Clin Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-021-00138-9","article-title":"Neurological manifestations of COVID-19-an approach to categories of pathology","volume":"3","author":"Leven Y","year":"2021","unstructured":"Leven Y, B\u00f6sel J. Neurological manifestations of COVID-19-an approach to categories of pathology. Neurol Res Pract. 2021, 3:39. 10.1186\/s42466-021-00138-9","journal-title":"Neurol Res Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103368","article-title":"Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis","volume":"57","author":"Michelena G","year":"2022","unstructured":"Michelena G, Casas M, Eizaguirre MB, et al.. Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis. Mult Scler Relat Disord. 2022, 57:103368. 10.1016\/j.msard.2021.103368","journal-title":"Mult Scler Relat Disord"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100979","article-title":"COVID-19 and multiple sclerosis: challenges and lessons for patient care","volume":"44","author":"Prosperini L","year":"2024","unstructured":"Prosperini L, Arrambide G, Celius EG, et al.. COVID-19 and multiple sclerosis: challenges and lessons for patient care. Lancet Reg Health Eur. 2024, 44:100979. 10.1016\/j.lanepe.2024.100979","journal-title":"Lancet Reg Health Eur"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ensci.2020.100299","article-title":"A first presentation of multiple sclerosis with concurrent COVID-19 infection","volume":"22","author":"Moore L","year":"2021","unstructured":"Moore L, Ghannam M, Manousakis G. A first presentation of multiple sclerosis with concurrent COVID-19 infection. eNeurologicalSci. 2021, 22:100299. 10.1016\/j.ensci.2020.100299","journal-title":"eNeurologicalSci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102377","article-title":"Multiple sclerosis following SARS-CoV-2 infection","volume":"45","author":"Palao M","year":"2020","unstructured":"Palao M, Fern\u00e1ndez-D\u00edaz E, Gracia-Gil J, Romero-S\u00e1nchez CM, D\u00edaz-Maroto I, Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord. 2020, 45:102377. 10.1016\/j.msard.2020.102377","journal-title":"Mult Scler Relat Disord"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6682251","article-title":"Demyelinating changes alike to multiple sclerosis: a case report of rare manifestations of COVID-19","volume":"2020","author":"Yavari F","year":"2020","unstructured":"Yavari F, Raji S, Moradi F, Saeidi M. Demyelinating changes alike to multiple sclerosis: a case report of rare manifestations of COVID-19. Case Rep Neurol Med. 2020, 2020:6682251. 10.1155\/2020\/6682251","journal-title":"Case Rep Neurol Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1287480","article-title":"Case report: a novel case of COVID-19 triggered tumefactive demyelinating lesions in one multiple sclerosis patient","volume":"17","author":"Hu J","year":"2023","unstructured":"Hu J, Huang L, Qiu Z, Liu Y, Shen K, Tang B, Qian J. Case report: a novel case of COVID-19 triggered tumefactive demyelinating lesions in one multiple sclerosis patient. Front Neurosci. 2023, 17:1287480. 10.3389\/fnins.2023.1287480","journal-title":"Front Neurosci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19036","article-title":"Multiple sclerosis following SARS-CoV-2 infection: a case report and literature review","volume":"13","author":"Sarwar S","year":"2021","unstructured":"Sarwar S, Rogers S, Mohamed AS, et al.. Multiple sclerosis following SARS-CoV-2 infection: a case report and literature review. Cureus. 2021, 13:e19036. 10.7759\/cureus.19036","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17297","article-title":"Demyelinating disease of the central nervous system concurrent with COVID-19","volume":"13","author":"Karsidag S","year":"2021","unstructured":"Karsidag S, Sahin S, Ates MF, Cinar N, Kendirli S. Demyelinating disease of the central nervous system concurrent with COVID-19. Cureus. 2021, 13:e17297. 10.7759\/cureus.17297","journal-title":"Cureus"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint13040066","article-title":"Clinical onset and multiple sclerosis relapse after SARS-CoV-2 infection","volume":"13","author":"Pignolo A","year":"2021","unstructured":"Pignolo A, Aprile M, Gagliardo C, et al.. Clinical onset and multiple sclerosis relapse after SARS-CoV-2 infection. Neurol Int. 2021, 13:695-700. 10.3390\/neurolint13040066","journal-title":"Neurol Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/334436-highly-aggressive-multiple-sclerosis-relapse-during-pregnancy-following-sars-cov-2-infection-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T01:36:59Z","timestamp":1740620219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/334436-highly-aggressive-multiple-sclerosis-relapse-during-pregnancy-following-sars-cov-2-infection-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.79718","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}